{
    "clinical_study": {
        "@rank": "16795", 
        "acronym": "PRESAGE-T2", 
        "arm_group": [
            {
                "arm_group_label": "New DELICAL formula", 
                "arm_group_type": "Experimental", 
                "description": "New high-protein oral nutrient supplement"
            }, 
            {
                "arm_group_label": "Standard DELICAL formula", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard isoenergetic isoprotein formula"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to determine whether a supplementation with a new\n      high-protein oral supplement can improve the evolution of functional parameters in elderly\n      patients in nursing homes."
        }, 
        "brief_title": "Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Malnutrition", 
        "condition_browse": {
            "mesh_term": "Malnutrition"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Man or woman aged more than 60 years old\n\n          -  Living in a nursing home for at least 2 months\n\n          -  Malnourished or at risk of malnutrition (MNA<23.5 or BMI<24 or albumin<35 g/l or\n             weight loss of more than 5 kg in the last 6 months)\n\n          -  Without dementia or with moderate dementia (MMSE > or =10/30)\n\n          -  Able to walk without human assistance (technical assistance allowed)\n\n          -  No vitamin D supplementation\n\n          -  Able to follow the study procedures and agreed to consume oral supplement\n\n        Exclusion Criteria:\n\n          -  Severe dementia (MMSE < 10/30)\n\n          -  Enteral nutrition\n\n          -  Severe renal or hepatic impairment\n\n          -  Cancer with chemotherapy\n\n          -  Uncontrolled diabetes\n\n          -  Lactose intolerance\n\n          -  Cow's milk protein allergy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02117609", 
            "org_study_id": "LRD-2011-PRESAGE", 
            "secondary_id": "ANR ALIA2010-01306 Presage"
        }, 
        "intervention": [
            {
                "arm_group_label": "New DELICAL formula", 
                "description": "3 months with the option of continuing until 6 months.", 
                "intervention_name": "New DELICAL formula", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Standard DELICAL formula", 
                "description": "3 months with the option of continuing until 6 months.", 
                "intervention_name": "Standard DELICAL formula", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elderly", 
            "Nursing home", 
            "Functional impairment", 
            "High-protein oral supplement"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toulouse", 
                    "country": "France"
                }, 
                "name": "Nursing homes - R\u00e9gion Midi-Pyr\u00e9n\u00e9es"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effet d'Une suppl\u00e9mentation Avec Une Nouvelle pr\u00e9paration hyperprot\u00e9in\u00e9e et Hypercalorique Sur l'\u00e9volution Des param\u00e8tres Fonctionnels, Nutritionnels et Cognitifs Chez la Personne \u00e2g\u00e9e en Institution", 
        "overall_contact": {
            "email": "rolland.y@chu-toulouse.fr", 
            "last_name": "Yves Rolland", 
            "phone": "+335 61 77 64 06"
        }, 
        "overall_official": [
            {
                "affiliation": "G\u00e9rontop\u00f4le Toulouse", 
                "last_name": "Yves Rolland, Pr", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Lactalis Nutrition Sant\u00e9", 
                "last_name": "C\u00e9cile Bonhomme, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "U995, Universit\u00e9 Lille Nord France", 
                "last_name": "David Seguy, Dr", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Lactalis Recherche et D\u00e9veloppement", 
                "last_name": "Charlotte Baudry, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in 4-meter walking speed", 
            "safety_issue": "No", 
            "time_frame": "After 3 months and 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02117609"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in grip strength", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "measure": "Change from baseline in ADL (Activities Daily Living) score", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "measure": "Change from baseline in Geriatric Depression Scale", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "measure": "Change from baseline in quality of life (QOL-AD)", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "measure": "Frequency of pathologic adverse events (disease, acute infection, falls, hospitalization)", 
                "safety_issue": "No", 
                "time_frame": "During the 3 months and/or 6 months of consumption"
            }, 
            {
                "measure": "Change from baseline in body composition measured by bioelectrical impedence analysis (BIA)", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "measure": "Change from baseline in nutritional status (Mini Nutritional Assessment)", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }, 
            {
                "description": "Inflammation markers (TNFalpha, TNF-R1, TNF-R2, IL 15), Fatty acid composition of red blood cell membranes, Fibrinogen, CRP, albumin, prealbumin, orosomucoid, IGF-1, cystein, glutathione peroxidase, oxidized and reduced glutathione", 
                "measure": "Changes from baseline in blood parameters", 
                "safety_issue": "No", 
                "time_frame": "After 3 months and 6 months"
            }
        ], 
        "source": "Lactalis", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "G\u00e9rontop\u00f4le Toulouse", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "U995, Universit\u00e9 Lille Nord de France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Research Agency, France", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Lactalis", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}